Dynamiker Biotechnology (Tianjin) Co., Ltd. Was founded in early 2014, a high-tech enterprise integrated with R&D, production and sales globally. It is focused on developing early, rapid and innovative in vitro diagnostics of invasive fungal diseases (IFD). The company is located at the Sino-Singapore Tianjin Eco-city in Tianjin Binhai New Area.

R&D Team

By adhering to the principle of "Technology is Power", the R&D team is consisted of domestic and overseas talented experts specialized in microbiology, immunology, molecular biology and clinical chemistry. Dr. Zeqi Zhou, who serves as the CTO of the team, obtained pH. D. From Ohio University and Postdoctoral training at Harvard Medical School. Having the extensive experience gained at Bayer and Wyeth, he LED the R&D team and successfully developed over 10 new IFD products that show strong competitiveness in the global market.

Market Development

Dynamiker's goal is to "shape company's brand with quality and explore world's market with innovation". Over 10 of the company's newly developed IFD kits have recently been CE marked. Dynamiker products have already penetrated the domestic market national-wide. Globally, Dynamiker products have entered into 26 countries in Asia, Europe, the Americas and Africa.

Customer Service

High quality is essential for market development and customer satisfaction. Dynamiker focuses on the needs of clients and continuously improves its quality of after-sales service. With the establishment of four-level after-sales service support system, including clinical centers, distributor's technical support team, Dynamiker's customer service team as well as R&D team, we have gained the trust and support from our customers.

Our Vision

Looking ahead, all of us are full of confidence and dynamics. Dynamiker will continue to uphold our enterprise spirit of "Unity, Practicability, Openness and Innovation". We are working together to make our company as a leader in IFD-IVD field and business market, to create an innovative national brand and have IPO launched in 5 years.